T1	tradename 104 111	ELIGARD
T3	tradename 184 191	ELIGARD
T5	activeingredient 193 212	leuprolide acetate)
T7	routeofadministration 228 240	subcutaneous
T9	fdaapprovaldate 274 278	2002
T11	tradename 508 515	ELIGARD
T13	indication 609 633	advanced prostate cancer
T15	dose 709 715	7.5 mg
T17	routeofadministration 716 730	subcutaneously
T19	frequency 731 742	every month
T21	dose 747 754	22.5 mg
T23	routeofadministration 755 769	subcutaneously
T25	frequency 770 784	every 3 months
T27	dose 789 794	30 mg
T29	routeofadministration 795 809	subcutaneously
T31	frequency 810 824	every 4 months
T33	dose 829 834	45 mg
T35	routeofadministration 835 849	subcutaneously
T37	frequency 850 864	every 6 months
T39	dose 962 968	7.5 mg
T41	dose 996 1003	22.5 mg
T43	dose 1031 1036	30 mg
T45	dose 1064 1069	45 mg
T47	tradename 1234 1241	ELIGARD
T49	adversereaction 1336 1347	Tumor Flare
T51	adversereaction 1723 1736	Hyperglycemia
T53	adversereaction 1741 1764	diabetes: Hyperglycemia
T55	adversereaction 1801 1809	diabetes
T57	adversereaction 1990 2011	myocardial infarction
T59	adversereaction 2013 2033	sudden cardiac death
T61	adversereaction 2038 2044	stroke
T63	adversereaction 2440 2447	Malaise
T65	adversereaction 2449 2456	fatigue
T67	adversereaction 2458 2476	hot flashes/sweats
T69	adversereaction 2482 2501	testicular atrophy.
T71	adversereaction 2571 2593	decreased bone density
T73	adversereaction 2612 2630	pituitary apoplexy
T75	company 2709 2731	TOLMAR Pharmaceuticals
T77	company 2733 2737	Inc.
T79	tradename 2892 2899	ELIGARD
T81	adversereaction 3340 3351	Tumor Flare
T83	adversereaction 3352 3353	5
T85	adversereaction 3377 3390	Hyperglycemia
T87	adversereaction 3395 3403	Diabetes
T89	adversereaction 3404 3405	5
T91	tradename 4182 4189	ELIGARD
T93	indication 4238 4263	advanced prostate cancer.
T95	tradename 4393 4400	ELIGARD
T97	activeingredient 4467 4485	leuprolide acetate
T99	activeingredient 4591 4609	leuprolide acetate
T101	tradename 4659 4666	ELIGARD
T103	tradename 4855 4862	ELIGARD
T105	tradename 5599 5606	ELIGARD
T107	tradename 5633 5640	ELIGARD
T109	activeingredient 5815 5833	leuprolide acetate
T111	activeingredient 6583 6602	leuprolide acetate.
T113	tradename 6843 6850	ELIGARD
T115	tradename 6888 6895	ELIGARD
T117	tradename 7481 7488	ELIGARD
T119	tradename 7961 7968	ELIGARD
T121	tradename 9587 9594	ELIGARD
T123	tradename 10143 10150	ELIGARD
T125	activeingredient 10182 10200	leuprolide acetate
T127	activeingredient 10570 10589	leuprolide acetate.
T129	tradename 10609 10616	ELIGARD
T131	tradename 10661 10668	ELIGARD
T133	tradename 10691 10698	ELIGARD
T135	adversereaction 10972 10988	Hypersensitivity
T137	tradename 10989 10996	ELIGARD
T139	adversereaction 11033 11049	hypersensitivity
T141	tradename 11108 11116	ELIGARD.
T143	adversereaction 11119 11141	Anaphylactic reactions
T145	tradename 11238 11245	ELIGARD
T147	tradename 11349 11356	ELIGARD
T149	tradename 11500 11507	ELIGARD
T151	adversereaction 11770 11781	Tumor Flare
T153	tradename 11782 11789	ELIGARD
T155	dose 11790 11810	7.5 mg 22.5 mg 30 mg
T157	tradename 11943 11950	ELIGARD
T159	dose 11951 11956	45 mg
T161	adversereaction 12200 12209	bone pain
T163	adversereaction 12211 12221	neuropathy
T165	adversereaction 12223 12232	hematuria
T167	adversereaction 12237 12264	bladder outlet obstruction.
T169	adversereaction 12277 12297	ureteral obstruction
T171	adversereaction 12305 12328	spinal cord compression
T173	indication 12451 12475	advanced prostate cancer
T175	adversereaction 12648 12671	spinal cord compression
T177	adversereaction 12675 12695	ureteral obstruction
T179	tradename 12804 12811	ELIGARD
T181	tradename 13265 13272	ELIGARD
T183	dose 13273 13280	7.5 mg.
T185	tradename 13435 13442	ELIGARD
T187	dose 13443 13451	22.5 mg.
T189	tradename 13493 13500	ELIGARD
T191	dose 13501 13506	30 mg
T193	tradename 13613 13620	ELIGARD
T195	dose 13621 13626	45 mg
T197	activeingredient 13983 14001	leuprolide acetate
T199	adversereaction 14204 14217	Hyperglycemia
T201	adversereaction 14222 14230	Diabetes
T203	adversereaction 14231 14244	Hyperglycemia
T205	adversereaction 14281 14289	diabetes
T207	adversereaction 14342 14355	Hyperglycemia
T209	adversereaction 14385 14402	diabetes mellitus
T211	adversereaction 14624 14637	hyperglycemia
T213	adversereaction 14641 14650	diabetes.
T215	adversereaction 14656 14679	Cardiovascular Diseases
T217	adversereaction 14680 14689	Increased
T219	adversereaction 14709 14730	myocardial infarction
T221	adversereaction 14732 14752	sudden cardiac death
T223	adversereaction 14757 14763	stroke
T225	adversereaction 15132 15154	cardiovascular disease
T227	tradename 15771 15778	ELIGARD
T229	indication 15849 15874	advanced prostate cancer.
T231	tradename 15904 15911	ELIGARD
T233	dose 15912 15918	7.5 mg
T235	tradename 15978 15985	ELIGARD
T237	dose 16720 16746	7.5 mg 22.5 mg 30 mg 45 mg
T239	frequency 16849 16860	every month
T241	duration 16861 16875	up to 6 months
T243	frequency 16888 16902	every 3 months
T245	duration 16903 16917	up to 6 months
T247	frequency 16930 16944	every 4 months
T249	duration 16945 16959	up to 8 months
T251	frequency 16972 16986	every 6 months
T253	duration 16987 17002	up to 12 months
T255	adversereaction 17579 17587	Bruising
T257	tradename 17943 17950	ELIGARD
T259	dose 17951 17959	22.5 mg.
T261	tradename 18342 18349	ELIGARD
T263	dose 18350 18356	30 mg.
T265	tradename 18383 18390	ELIGARD
T267	dose 18391 18396	30 mg
T269	tradename 18621 18628	ELIGARD
T271	dose 18629 18635	45 mg.
T273	tradename 18778 18785	ELIGARD
T275	dose 18786 18792	45 mg.
T277	tradename 19033 19040	ELIGARD
T279	indication 19156 19183	metastatic prostate cancer.
T281	tradename 19356 19363	ELIGARD
T283	dose 19368 19401	7.5 mg 7.5 mg 22.5 mg 30 mg 45 mg
T285	dose 19402 19407	Study
T287	frequency 19513 19524	every month
T289	duration 19525 19539	up to 6 months
T291	frequency 19596 19610	every 3 months
T293	duration 19611 19625	up to 6 months
T295	frequency 19638 19652	every 4 months
T297	duration 19653 19667	up to 8 months
T299	frequency 19680 19694	every 6 months
T301	duration 19695 19710	up to 12 months
T303	adversereaction 19771 19778	Malaise
T305	adversereaction 19783 19790	Fatigue
T307	adversereaction 19834 19842	Weakness
T309	adversereaction 19868 19877	Dizziness
T311	adversereaction 19905 19923	Hot flashes/sweats
T313	adversereaction 19998 20015	Urinary frequency
T315	adversereaction 20034 20042	Nocturia
T317	adversereaction 20070 20076	Nausea
T319	adversereaction 20095 20118	Gastroenteritis/colitis
T321	adversereaction 20134 20142	Pruritis
T323	adversereaction 20152 20162	Clamminess
T325	adversereaction 20173 20185	Night sweats
T327	adversereaction 20206 20214	Alopecia
T329	adversereaction 20240 20250	Arthralgia
T331	adversereaction 20260 20267	Myalgia
T333	adversereaction 20286 20298	Pain in limb
T335	adversereaction 20322 20340	Testicular atrophy
T337	adversereaction 20370 20382	Gynecomastia
T339	adversereaction 20403 20418	Testicular pain
T341	adversereaction 20440 20456	Decreased libido
T343	tradename 20576 20583	ELIGARD
T345	dose 20584 20590	7.5 mg
T347	adversereaction 20606 20624	hot flashes/sweats
T349	tradename 20790 20797	ELIGARD
T351	dose 20798 20805	22.5 mg
T353	adversereaction 20821 20839	hot flashes/sweats
T355	tradename 21004 21011	ELIGARD
T357	dose 21012 21017	30 mg
T359	adversereaction 21033 21042	hot flash
T361	tradename 21209 21216	ELIGARD
T363	dose 21217 21222	45 mg
T365	adversereaction 21238 21247	hot flash
T367	tradename 21508 21515	ELIGARD
T369	adversereaction 21582 21590	Sweating
T371	adversereaction 21592 21600	insomnia
T373	adversereaction 21602 21609	syncope
T375	adversereaction 21611 21617	rigors
T377	adversereaction 21619 21627	weakness
T379	adversereaction 21629 21637	lethargy
T381	adversereaction 21655 21665	Flatulence
T383	adversereaction 21667 21679	constipation
T385	adversereaction 21681 21690	dyspepsia
T387	adversereaction 21691 21733	Hematologic Decreased red blood cell count
T389	adversereaction 21735 21760	hematocrit and hemoglobin
T391	adversereaction 21761 21782	Metabolic Weight gain
T393	adversereaction 21783 21805	Musculoskeletal Tremor
T395	adversereaction 21807 21815	backache
T397	adversereaction 21817 21827	joint pain
T399	adversereaction 21829 21843	muscle atrophy
T401	adversereaction 21845 21854	limb pain
T403	adversereaction 21855 21893	Nervous Disturbance of smell and taste
T405	adversereaction 21895 21905	depression
T407	adversereaction 21907 21914	vertigo
T409	adversereaction 21915 21935	Psychiatric Insomnia
T411	adversereaction 21937 21947	depression
T413	adversereaction 21949 21964	loss of libido*
T415	adversereaction 21979 22006	Difficulties with urination
T417	adversereaction 22008 22025	pain on urination
T419	adversereaction 22027 22043	scanty urination
T421	adversereaction 22045 22058	bladder spasm
T423	adversereaction 22060 22074	blood in urine
T425	adversereaction 22076 22093	urinary retention
T427	adversereaction 22095 22110	urinary urgency
T429	adversereaction 22112 22124	incontinence
T431	adversereaction 22126 22134	nocturia
T433	adversereaction 22136 22155	nocturia aggravated
T435	adversereaction 22182 22206	Testicular soreness/pain
T437	adversereaction 22208 22218	impotence*
T439	adversereaction 22239 22252	gynecomastia*
T441	adversereaction 22254 22281	breast soreness/tenderness*
T443	adversereaction 22283 22302	testicular atrophy*
T445	adversereaction 22304 22324	erectile dysfunction
T447	adversereaction 22326 22342	penile disorder*
T449	adversereaction 22344 22362	reduced penis size
T451	adversereaction 22369 22377	Alopecia
T453	adversereaction 22379 22389	clamminess
T455	adversereaction 22391 22404	night sweats*
T457	adversereaction 22406 22425	sweating increased*
T459	adversereaction 22436 22448	Hypertension
T461	adversereaction 22450 22461	hypotension
T463	adversereaction 22533 22557	Changes in Bone Density:
T465	adversereaction 22897 22915	pituitary apoplexy
T467	adversereaction 23106 23123	pituitary adenoma
T469	adversereaction 23157 23175	pituitary apoplexy
T471	adversereaction 23275 23293	pituitary apoplexy
T473	adversereaction 23311 23326	sudden headache
T475	adversereaction 23328 23336	vomiting
T477	adversereaction 23338 23352	visual changes
T479	adversereaction 23354 23369	ophthalmoplegia
T481	adversereaction 23371 23392	altered mental status
T483	adversereaction 23408 23432	cardiovascular collapse.
T485	adversereaction 23482 23493	Convulsions
T487	tradename 23640 23647	ELIGARD
T489	tradename 23754 23761	ELIGARD
T491	tradename 23890 23897	ELIGARD
T493	activeingredient 24257 24275	leuprolide acetate
T495	tradename 24593 24603	ELIGARD is
T497	tradename 24860 24867	Eligard
T499	tradename 25067 25074	ELIGARD
T501	frequency 25290 25295	daily
T503	routeofadministration 25296 25308	subcutaneous
T505	activeingredient 25323 25341	leuprolide acetate
T507	indication 25359 25374	prostate cancer
T509	dose 25393 25398	20 mg
T511	frequency 25398 25402	/day
T513	duration 25413 25422	two years
T515	dose 25488 25492	1 mg
T517	frequency 25492 25496	/day
T519	tradename 25520 25527	ELIGARD
T521	nanoparticle 25541 25557	polymeric matrix
T523	activeingredient 25573 25591	leuprolide acetate
T525	routeofadministration 25613 25625	subcutaneous
T527	activeingredient 25664 25682	leuprolide acetate
T529	activeingredient 25766 25784	Leuprolide acetate
T531	tradename 26256 26263	ELIGARD
T533	tradename 26477 26484	ELIGARD
T535	routeofadministration 26501 26515	subcutaneously
T537	activeingredient 26636 26655	leuprolide acetate.
T539	corecomposition 26751 26795	poly (DL-lactide-co-glycolide) (PLGH or PLG)
T541	inactiveingredient 26854 26883	N-methyl-2-pyrrolidone (NMP).
T543	tradename 26983 26990	ELIGARD
T545	tradename 27019 27026	ELIGARD
T547	tradename 27091 27098	ELIGARD
T549	dose 27102 27108	7.5 mg
T551	tradename 27109 27116	ELIGARD
T553	dose 27120 27127	22.5 mg
T555	tradename 27128 27135	ELIGARD
T557	dose 27136 27141	30 mg
T559	tradename 27142 27149	ELIGARD
T561	dose 27150 27155	45 mg
T563	activeingredient 27544 27562	Leuprolide acetate
T565	activeingredient 27859 27877	Leuprolide acetate
T567	activeingredient 28124 28142	leuprolide acetate
T569	activeingredient 28305 28323	leuprolide acetate
T571	activeingredient 28652 28670	leuprolide acetate
T573	activeingredient 28938 28956	leuprolide acetate
T575	tradename 29080 29087	ELIGARD
T577	tradename 29232 29239	ELIGARD
T579	frequency 29267 29274	monthly
T581	tradename 29290 29297	ELIGARD
T583	dose 29298 29304	7.5 mg
T585	tradename 29599 29606	ELIGARD
T587	dose 29607 29614	22.5 mg
T589	tradename 30220 30227	ELIGARD
T591	dose 30228 30233	30 mg
T593	tradename 30717 30724	ELIGARD
T595	dose 30725 30730	45 mg
T597	activeingredient 31150 31168	Leuprolide acetate
T599	routeofadministration 31194 31201	orally.
T601	tradename 31236 31243	ELIGARD
T603	dose 31244 31250	7.5 mg
T605	cmax 31482 31492	25.3 ng/mL
T607	tmax 31517 31524	5 hours
T609	tradename 31730 31737	ELIGARD
T611	dose 31738 31744	7.5 mg
T613	tradename 31917 31924	ELIGARD
T615	dose 31925 31931	7.5 mg
T617	tradename 31946 31953	ELIGARD
T619	dose 31954 31961	22.5 mg
T621	dose 31962 31965	The
T623	tradename 32051 32058	ELIGARD
T625	dose 32059 32067	22.5 mg)
T627	tradename 32476 32483	ELIGARD
T629	dose 32484 32491	22.5 mg
T631	tradename 32533 32540	ELIGARD
T633	dose 32541 32546	30 mg
T635	tradename 32655 32662	ELIGARD
T637	dose 32663 32668	30 mg
T639	indication 32691 32715	advanced prostate cancer
T641	cmax 32826 32835	150 ng/mL
T643	tmax 32860 32869	3.3 hours
T645	tradename 33078 33085	ELIGARD
T647	dose 33086 33091	30 mg
T649	tradename 33133 33140	ELIGARD
T651	dose 33141 33146	45 mg
T653	dose 33147 33150	The
T655	tradename 33254 33261	ELIGARD
T657	dose 33262 33268	45 mg)
T659	cmax 33384 33406	82 ng/mL and 102 ng/mL
T661	tmax 33431 33440	4.5 hours
T663	tradename 33691 33698	ELIGARD
T665	dose 33699 33704	45 mg
T667	tradename 33912 33919	ELIGARD
T669	routeofadministration 34080 34091	intravenous
T671	volumeofdistribution 34144 34149	27 L.
T673	dose 34261 34265	1-mg
T675	clearance 34359 34367	8.34 L/h
T677	plasmahalflife 34424 34431	3 hours
T679	tradename 34511 34519	ELIGARD.
T681	activeingredient 34557 34575	leuprolide acetate
T683	activeingredient 34614 34632	leuprolide acetate
T685	tradename 34724 34731	ELIGARD
T687	tradename 35006 35013	ELIGARD
T689	dose 35014 35020	7.5 mg
T691	tradename 35021 35028	ELIGARD
T693	dose 35029 35036	22.5 mg
T695	tradename 35037 35044	ELIGARD
T697	dose 35045 35050	30 mg
T699	tradename 35051 35058	ELIGARD
T701	dose 35062 35067	45 mg
T703	tradename 35176 35183	ELIGARD
T705	activeingredient 35398 35416	leuprolide acetate
T707	dose 35620 35635	0.6 to 4 mg/kg)
T709	activeingredient 35849 35875	leuprolide acetate-induced
T711	dose 35945 35953	60 mg/kg
T713	duration 35958 35968	two years.
T715	activeingredient 36002 36020	leuprolide acetate
T717	duration 36025 36042	up to three years
T719	dose 36065 36070	10 mg
T721	frequency 36070 36074	/day
T723	duration 36083 36092	two years
T725	dose 36115 36120	20 mg
T727	frequency 36120 36124	/day
T729	tradename 36224 36232	ELIGARD.
T731	activeingredient 36280 36298	leuprolide acetate
T733	tradename 36346 36353	ELIGARD
T735	dose 36354 36360	7.5 mg
T737	tradename 36526 36533	ELIGARD
T739	dose 36547 36553	7.5 mg
T741	dose 36555 36562	22.5 mg
T743	dose 36564 36569	30 mg
T745	dose 36575 36581	45 mg)
T747	tradename 36892 36899	ELIGARD
T749	dose 36900 36906	7.5 mg
T751	tradename 37083 37090	ELIGARD
T753	dose 37091 37098	22.5 mg
T755	tradename 37345 37352	ELIGARD
T757	dose 37353 37358	30 mg
T759	tradename 38532 38539	ELIGARD
T761	dose 38540 38545	45 mg
T763	tradename 38859 38866	ELIGARD
T765	dose 38884 38910	7.5 mg 22.5 mg 30 mg 45 mg
T767	frequency 39284 39302	every three months
T769	frequency 39337 39354	every four months
T771	frequency 39388 39404	every six months
T773	duration 39441 39477	6 months 6 months 8 months 12 months
T775	tradename 40818 40825	ELIGARD
T777	dose 40826 40832	7.5 mg
T779	tradename 40892 40899	ELIGARD
T781	dose 40900 40907	22.5 mg
T783	tradename 40967 40974	ELIGARD
T785	dose 40975 40980	30 mg
T787	tradename 41039 41046	ELIGARD
T789	dose 41047 41052	45 mg
T791	tradename 41268 41275	ELIGARD
T793	tradename 41326 41333	ELIGARD
T795	tradename 41362 41369	ELIGARD
T797	dose 41370 41396	7.5 mg 22.5 mg 30 mg 45 mg
T799	tradename 41805 41812	ELIGARD
T801	dose 41813 41819	7.5 mg
T803	tradename 41820 41827	ELIGARD
T805	dose 41828 41835	22.5 mg
T807	tradename 41836 41843	ELIGARD
T809	dose 41844 41849	30 mg
T811	tradename 41850 41857	ELIGARD
T813	dose 41858 41863	45 mg
T815	tradename 43250 43257	ELIGARD
T817	tradename 43373 43380	ELIGARD
T819	dose 43381 43387	7.5 mg
T821	tradename 43406 43413	ELIGARD
T823	dose 43414 43421	22.5 mg
T825	tradename 43440 43447	ELIGARD
T827	dose 43448 43453	30 mg
T829	tradename 43472 43479	ELIGARD
T831	dose 43480 43485	45 mg
T833	tradename 43506 43513	ELIGARD
T835	tradename 43636 43643	ELIGARD
T837	dose 43644 43650	7.5 mg
T839	tradename 43669 43676	ELIGARD
T841	dose 43677 43684	22.5 mg
T843	tradename 43703 43710	ELIGARD
T845	dose 43711 43716	30 mg
T847	tradename 43735 43742	ELIGARD
T849	dose 43743 43748	45 mg
T851	adversereaction 43906 43918	hot flashes.
T853	adversereaction 44000 44009	bone pain
T855	adversereaction 44021 44044	difficulty in urinating
T857	adversereaction 44078 44086	weakness
T859	adversereaction 44090 44100	paralysis.
T861	tradename 44195 44202	ELIGARD
T863	company 44620 44631	TOLMAR Inc.
T865	company 44660 44679	TOLMAR Therapeutics
T867	company 44681 44685	Inc.
T869	company 44727 44749	TOLMAR Pharmaceuticals
T871	company 44751 44755	Inc.
T873	company 44786 44808	TOLMAR Pharmaceuticals
T875	company 44810 44814	Inc.
